瘤微环境控制了头支状细胞癌免疫疗法的预后格局:以计算模型为指导的分析
Priyan Bhattacharya1, Alban Linnenbach2, Andrew P South3
1Department of Pathology and Genomic Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America.
PLoS computational biology
|June 3, 2025
概括
这项研究模拟了头部和部状细胞癌瘤微环境 (TME),以了解免疫检查点抑制 (ICI) 抵抗. 独特的TME亚型影响ICI反应,预测特定的疗法和生物标志物可以改善结果.
科学领域:
- 计算生物学是一种计算生物学.
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 免疫检查点抑制 (ICI) 对于治疗头部和部状细胞癌 (HNSCC) 至关重要.
- 瘤微环境 (TME) 相互作用显著影响HNSCC对ICI的反应.
- 了解各种TME亚型及其对ICI疗效的影响至关重要.
研究的目的:
- 开发HNSCC TME的细胞分子模型.
- 识别不同的TME亚型及其与ICI响应的相关性.
- 预测ICI耐药HNSCC的新型治疗策略和生物标志物.
主要方法:
- 开发了一个HNSCC TME的细胞分子模型.
- 模拟多种细胞类型,状态和分子信号之间的相互作用.
- 分析参数空间以识别不同的TME亚型.
主要成果:
- 确定了五种临床观察到的HNSCC TME亚型.
- 预测与癌症相关的纤维细胞阻碍CD8+T细胞透,恶化ICI反应.
- 在免疫沙漠情景中展示了IL-2 + ICI联合治疗的潜在好处.
- 在纤维主导的场景中,确定了骨质疏松素 (OPN) 和白血病抑制因子 (LIF) 淘汰作为有益的.
- 预测IL-8和乳酸作为ICI耐药性的生物标志物.
结论:
- 开发的模型为理解HNSCC中TME介导的ICI电阻提供了一个定量框架.
- 特定的TME亚型需要量身定制的治疗方法来改善ICI结果.
- 鉴定了介质素-8 (IL-8) 和乳酸盐作为预测HNSCC中的ICI耐药性的潜在生物标志物.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493


